| Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study K Hermelink, M Untch, MP Lux, R Kreienberg, T Beck, I Bauerfeind, ... Cancer 109 (9), 1905-1913, 2007 | 436 | 2007 |
| Two different sides of ‘chemobrain’: determinants and nondeterminants of self‐perceived cognitive dysfunction in a prospective, randomized, multicenter study K Hermelink, H Küchenhoff, M Untch, I Bauerfeind, MP Lux, M Bühner, ... Psycho‐oncology 19 (12), 1321-1328, 2010 | 179 | 2010 |
| Short‐term effects of treatment‐induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study K Hermelink, V Henschel, M Untch, I Bauerfeind, MP Lux, K Munzel Cancer 113 (9), 2431-2439, 2008 | 112 | 2008 |
| Elucidating pretreatment cognitive impairment in breast cancer patients: the impact of cancer-related post-traumatic stress K Hermelink, V Voigt, J Kaste, F Neufeld, R Wuerstlein, M Bühner, ... Journal of the National Cancer Institute 107 (7), djv099, 2015 | 107 | 2015 |
| Chemotherapy and post-traumatic stress in the causation of cognitive dysfunction in breast cancer patients K Hermelink, M Bühner, P Sckopke, F Neufeld, J Kaste, V Voigt, K Münzel, ... JNCI: Journal of the National Cancer Institute 109 (10), djx057, 2017 | 103 | 2017 |
| Chemotherapy and cognitive function in breast cancer patients: the so-called chemo brain K Hermelink Journal of the National Cancer Institute Monographs 2015 (51), 67-69, 2015 | 103 | 2015 |
| Clinically assessed posttraumatic stress in patients with breast cancer during the first year after diagnosis in the prospective, longitudinal, controlled COGNICARES study V Voigt, F Neufeld, J Kaste, M Bühner, P Sckopke, R Wuerstlein, ... Psycho‐Oncology 26 (1), 74-80, 2017 | 84 | 2017 |
| Menopausal status in breast cancer patients with past chemotherapy determines long-term hypoactive sexual desire disorder R Ochsenkühn, K Hermelink, AH Clayton, V von Schönfeldt, J Gallwas, ... The Journal of Sexual Medicine 8 (5), 1486-1494, 2011 | 53 | 2011 |
| International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the fifth symposium on primary systemic therapy in the … V Amoroso, D Generali, T Buchholz, M Cristofanilli, R Pedersini, ... Journal of the National Cancer Institute Monographs 2015 (51), 90-96, 2015 | 49 | 2015 |
| Immunotherapy: new options in breast cancer treatment M Untch, N Ditsch, K Hermelink Informa Healthcare 3 (3), 403-408, 2003 | 48 | 2003 |
| Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer A Vattai, E Akyol, C Kuhn, S Hofmann, H Heidegger, F von Koch, ... Journal of cancer research and clinical oncology 143, 1637-1647, 2017 | 40 | 2017 |
| Factors associated with the decline of psychological support in hospitalized patients with cancer T Pichler, A Dinkel, B Marten‐Mittag, K Hermelink, E Telzerow, ... Psycho‐Oncology, 2019 | 34 | 2019 |
| EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer A Semmlinger, V von Schoenfeldt, V Wolf, A Meuter, TM Kolben, T Kolben, ... BMC cancer 18, 1-9, 2018 | 27 | 2018 |
| Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration E Tremmel, S Hofmann, C Kuhn, H Heidegger, S Heublein, K Hermelink, ... Breast Cancer: Targets and Therapy, 87-97, 2019 | 19 | 2019 |
| TAAR1 induces a disturbed GSK3β phosphorylation in recurrent miscarriages through the ODC S Stavrou, M Gratz, E Tremmel, C Kuhn, S Hofmann, H Heidegger, ... Endocrine Connections 7 (2), 372-384, 2018 | 14 | 2018 |
| Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer A Vattai, V Cavailles, S Sixou, S Beyer, C Kuhn, M Peryanova, ... Oncotarget 8 (62), 105356, 2017 | 14 | 2017 |
| Dopamine synthesis and dopamine receptor expression are disturbed in recurrent miscarriages MJ Gratz, S Stavrou, C Kuhn, S Hofmann, K Hermelink, H Heidegger, ... Endocrine connections 7 (5), 727-738, 2018 | 10 | 2018 |
| Distress in hospitalized cancer patients: Associations with personality traits, clinical and psychosocial characteristics T Pichler, B Marten‐Mittag, K Hermelink, E Telzerow, T Frank, ... Psycho‐Oncology 31 (5), 770-778, 2022 | 7 | 2022 |
| Brief Distress Screening in Clinical Practice: Does it Help to Effectively Allocate Psycho-Oncological Support to Female Cancer Inpatients? K Hermelink, H Höhn, S Hasmüller, J Gallwas, K Haertl, R Wuerstlein, ... Breast Care 9 (2), 129-129, 2014 | 7 | 2014 |
| Congruence and trajectories of device-measured and self-reported physical activity during therapy for early breast cancer H Helbrich, M Braun, C Hanusch, G Mueller, H Falk, R Flondor, ... Breast Cancer Research and Treatment 188, 351-359, 2021 | 5 | 2021 |
